X0306 4 2019-03-07 0000812074 OWENS ILLINOIS INC /DE/ OI 0001663388 Connors Timothy M. ONE MICHAEL OWENS WAY PERRYSBURG OH 43551 1 President, O-I Asia Pacific Common Stock (Direct) 2019-03-07 4 A 0 19934.0000 0.0000 A 48105.0000 D Common Stock (Direct) 2019-03-07 4 A 0 8176.0000 0.0000 A 56281.0000 D Common Stock (Direct) 2019-03-07 4 M 0 300.0000 15.0500 A 56581.0000 D Common Stock (Direct) 2019-03-07 4 S 0 300.0000 19.6800 D 56281.0000 D Common Stock (Direct) 2019-03-07 4 S 0 6382.0000 19.7449 D 49899.0000 D Common Stock (Direct) 2019-03-07 4 S 0 7104.0000 19.6459 D 42795.0000 D Common Stock (Direct) 2019-03-07 4 S 0 19934.0000 19.5215 D 22861.0000 D Common Stock (Direct) 2019-03-08 4 M 0 10995.0000 15.0500 A 33856.0000 D Common Stock (Direct) 2019-03-08 4 S 0 10995.0000 19.4184 D 22861.0000 D Common Stock (Indirect) 900.0910 I By 401k Stock Option 03/07/2016 $15.05 15.0500 2019-03-07 4 M 0 300.0000 0.0000 D 2017-03-07 2023-03-07 Common Stock (Direct) 300.0000 14760.0000 D Stock Option 03/07/2016 $15.05 15.0500 2019-03-08 4 M 0 10995.0000 0.0000 D 2017-03-07 2023-03-07 Common Stock (Direct) 10995.0000 3765.0000 D Certain restricted stock units granted for the 2016-2018 grant period vest in the form of common stock based upon the Issuer's performance against certain strategic objective goals. On March 7, 2019, the Compensation Committee of the Issuer's Board of Directors determined that the strategic objective goals had been met, resulting in the vesting of these shares. The restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.70 to $19.895, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.63 to $19.675, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.44 to $19.64, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.40 to $19.485, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The options become exercisable in annual 25% increments beginning on the first anniversary of the grant date, March 7, 2017. /s/Mary Beth Wilkinson, attorney-in-fact 2019-03-11